Experienced in Intrauterine Growth Restriction

Martin Meuli

Zurich, ZH, CH 
Experienced in Intrauterine Growth Restriction
Zurich, ZH, CH 
OverviewLocationsClinical Research

Overview

Martin Meuli practices in Zurich, Switzerland. Mr. Meuli is rated as an Experienced expert by MediFind in the treatment of Intrauterine Growth Restriction. His top areas of expertise are Myelomeningocele, Neurogenic Bladder, Vasoconstriction, Atresia of Small Intestine, and Endoscopy.

His clinical research consists of co-authoring 112 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Intrauterine Growth Restriction.

Gender
Male

Locations

Zurich, ZH, Switzerland
Other Locations
Schlieren, ZH 8952, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase IIb, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Partial Deep Dermal and Full Thickness Burns in Children in Comparison to Autologous Split-thickness Skin Grafts (STSG)
A Phase IIb, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Partial Deep Dermal and Full Thickness Burns in Children in Comparison to Autologous Split-thickness Skin Grafts (STSG)
Enrollment Status: Active_not_recruiting
Publish Date: May 22, 2025
Intervention Type: Biological
Study Phase: Phase 2
A Phase II, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Full-Thickness Defects in Adults and Children in Comparison to Autologous Split-thickness Skin Grafts (STSG)
A Phase II, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Full-Thickness Defects in Adults and Children in Comparison to Autologous Split-thickness Skin Grafts (STSG)
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2025
Intervention Type: Biological
Study Phase: Phase 2
A Phase I, Two Armed, Open, Prospective and Multicentre Study to Evaluate the Safety of Autologous Tissue-engineered Dermal Substitutes and Dermo-epidermal Skin Substitutes for the Treatment of Large Deep Partial and Full Thickness Skin Defects in Children and Adults
A Phase I, Two Armed, Open, Prospective and Multicentre Study to Evaluate the Safety of Autologous Tissue-engineered Dermal Substitutes and Dermo-epidermal Skin Substitutes for the Treatment of Large Deep Partial and Full Thickness Skin Defects in Children and Adults
Enrollment Status: Completed
Publish Date: September 08, 2021
Intervention Type: Biological
Study Phase: Phase 1
View 2 Less Clinical Trials

111 Total Publications

Normalization of the middle cerebral artery resistance index (MCA-RI) - a sign for adequate untethering of the spinal cord and regression of hindbrain herniation after fetal spina bifida repair?
Normalization of the middle cerebral artery resistance index (MCA-RI) - a sign for adequate untethering of the spinal cord and regression of hindbrain herniation after fetal spina bifida repair?
Journal: Fetal diagnosis and therapy
Published: January 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Meuli's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile